There are few studies on the incidence of dementia in representative minority populations in the United States; however, no population-based study has been conducted on Japanese American women. We identified 3045 individuals aged 65 + with at least 1 parent of Japanese descent living in King County, WA in the period 1992 to 1994, of whom 1836 were dementia-free and were examined every 2 years (1994 to 2001) to identify incident cases of all dementias, Alzheimer disease (AD), vascular dementia (VaD), and other dementias. Cox regression was used to examine associations with age, sex, years of education, and apolipoprotein (APOE)-E4. Among 173 incident cases of dementia, the overall rate was 14.4/1000/y, with rates being slightly higher among women (15.9/1000) than men (12.5/1000). Rates roughly doubled every 5 years for dementia and AD; the age trend for VaD and other dementias was less consistent. Sex was not significantly related to incidence of dementia or its subtypes in adjusted models. There was a trend for an inverse association with increasing years of education. APOE-E4 was a strong risk factor for all dementias [hazard ratio (HR) = 2.89; 95% confidence interval (CI), 1.88-4.46], AD (HR = 3.27; 95% CI, 2.03-5.28), and VaD (HR = 3.33; 95% CI, 1. 34-8.27). This study is the first to report population-based incidence rates for both Japanese American men and women.
M arked geographic differences in the relative proportions of dementia subtypes were thought to exist in the 1980s to 1990s between Asia and the West, with Alzheimer disease (AD) accounting for the majority of cases in the West and vascular dementia (VaD) being more common in Asia. 1 The Ni-Hon-Sea Project was conducted in Hiroshima, Japan (The Adult Health Study); Honolulu, Hawaii [Honolulu-Asia Aging Study (HAAS)]; and Seattle, WA (Kame Project) to examine prevalence and incidence rates and risk factors for dementia and its subtypes among Japanese populations in Japan and among immigrants and US-born individuals, with the goal to discover whether rates of AD increase with migration to the West. 2 Incidence rates for dementia and its subtypes from Japanese American populations have been published from the Honolulu-Asia Aging Study, which included only men. 3 The Kame Project is the first population-based study of dementia among community-dwelling Japanese American men and women.
METHODS

Study Population
Identification and recruitment of the baseline population has been described previously. 1 A study census was conducted of all Japanese Americans in King County, WA aged 55 and over, representing 90% of all Japanese Americans of this age group as identified by the 1990 US census. 1 The study is named Kame (pronounced kah-meh) after the turtle, the Japanese symbol of longevity. Ninetysix percent of the population had 2 parents of Japanese origin; the remainder had 1. Of 3062 eligible residents age 65 and over, 3045 were alive and invited and 1985 (65.2%) agreed to participate in the baseline examination (May 1992 to May 1994). Of these, 149 were found to have prevalent dementia 1 ; the remaining 1836 were considered dementia-free.
Procedures
Baseline Evaluation
Baseline evaluations were conducted from 1992 to 1994 in English or Japanese (21.6%). Highly structured interviews were administered in-person by trained interviewers to gather risk factor data from nondemented participants.
We screened for dementia using the Cognitive Abilities Screening Instrument (CASI) 4 Figure 1 shows the numbers of participants alive and those lost to follow-up at each successive wave. At each incidence wave, participants scoring <87/100 on the CASI were invited for proxy, neurological, and neuropsychological evaluations. A cutoff point of 87 was selected to provide high sensitivity; at baseline, a CASI score of 86 had a sensitivity of 0.94 and a specificity of 0.94 for dementia. 4 Proxy interviews included the Clinical Dementia Rating Scale, 5 Blessed Dementia Rating Scale, 6 and Informant Questionnaire on Cognitive Decline in the Elderly. 7 Standard neuropsychological batteries were administered by a trained psychometrist and interpreted by a geriatric neuropsychologist (J.U./S.M.M.), and clinical and neurological examinations were performed by a neurologist (J.D.B.) or a geriatrician (W.C.M.). The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery was used, 8 excluding the MMSE, which is embedded in the CASI. Additional tests included: the Wechsler Memory Scale-Revised, Verbal Paired Associates (immediate and delayed recall), 9 Trailmaking Test Parts A and B, 10 Digit Span and Digit Symbol subtests of the Wechsler Adult Intelligence Scale-Revised, 11 and the CES-D. 12 Participants suspected of having dementia underwent standard laboratory evaluations and some of these underwent noncontrast computed tomography brain scans.
Dementia and subtype diagnoses were made by a consensus committee (J.D.B., W.C.M., S.M.M., J.U., and A.R.B.,), utilizing the Diagnostic and Statistical Manual IV (DSM-IV) 13 blinded to CASI scores. The DSM-IV criterion of "impairment in social or occupational functionyand decline from a previous level of functioning" was judged by changes in job performance, household responsibilities, hobbies, community and driving ability, or personal activities. The NINCDS-ADRDA criteria 14 were used to classify probable/possible AD and the NINDS-AIREN criteria 15 for probable/possible VaD. Possible AD and possible VaD were not mutually exclusive, and some participants received both diagnoses. We report here incidence rates for all dementias (DSM-IV), probable and possible AD, probable and possible VaD, and other dementias.
Between 1994 and 1996, the cohort was invited to a blood draw to genotype the apolipoprotein E gene (APOE) 16 ; 65.6% participated. Other variables used here (age, sex, and years of education) were self-reported from the risk factor questionnaire.
All participants gave written informed consent, and the study was approved by the University of Washington and University of South Florida Institutional Review Boards.
Statistical Analysis
Incidence rates for dementia, AD, and VaD were calculated using person-years. Crude rates were determined by dividing the number of new cases by the number of person-years at risk in the 5-year age stratum beginning at age 65 and ending with age 95 + (expressed per 1000/y). Age was used as the time scale, such that for each nondemented participant, the number of person-years contributed was the difference between the age at study entry (left-truncation) and the age at last biennial examination. For demented participants, the age at which dementia occurred was the midpoint between the latest examination in which they were considered nondemented and the first examination in which they received a dementia diagnosis. Ninety-five percent confidence intervals (CI) for incidence rates were derived assuming a Poisson distribution for the number of cases within each age stratum.
Multiple imputation techniques were used to adjust for participants who became demented at the first biennial visit but had missing values on dementia status at baseline because of not being sampled, or were sampled but did not come in for the baseline diagnostic examination (n = 68). The imputations were based on the probability of dementia given CASI and baseline age. 17 The imputations account for any differences in the numerators and denominators in the tables.
Age, sex, level of education (continuous and categorical, analyzed in this population as <8, 9 to 11, 12, and Z13 y), and APOE genotype (presence or absence of an E4 allele) were examined using Cox proportional hazards regression models with age as the time scale left-truncated at baseline age. Hazard ratios (HR) are reported with 95% CI and P-values. All analyses including multiple imputation macros were performed using SAS 9.3 (Cary, NC).
RESULTS
From the nondemented cohort (N = 1836), 454 scored below 87 on the CASI during the follow-up period and received full clinical evaluations; 173 of these met criteria for incident dementia. Figure 1 shows the number of incident cases at each wave and those lost to follow-up (1992 to 2001). Table 1 depicts the total number of incident cases arising during the follow-up period (1994 to 2001). As participants could meet either probable or possible NINCDS/ADRDA and probable or possible NINDS-AIREN criteria (eg, probable AD by NINCDS/ADRDA and possible VaD by NINCDS/AIREN, or possible AD and possible VaD), the numbers shown are not mutually exclusive. There were 17 other dementias, 1 due to vascular disease, 2 due to Parkinson disease, 2 due to head trauma, 5 due to other general medical conditions, 1 substanceinduced dementia, 4 due to multiple etiologies, and 2 due to unknown causes. Table 2 shows baseline characteristics of the participants who did and did not become demented during follow-up. Women who developed dementia were older than men who developed dementia (P = 0.008). Cohort participants who remained unaffected had more education than those who became demented (1.6 y more education for men and 0.8 y more education for women) (P < 0.0001). About 20% of the cohort had 1 or 2 APOE-E4 alleles, with 38.5% of incident cases and 18.8% of unaffected participants possessing an APOE-E4 allele, with no differences by sex (P = 0.36).
We imputed incidence rates for 68 individuals who were sampled at baseline for the prevalence phase, but who did not come in for clinical evaluation until the first incidence wave. Of these 68, 18 were found to have incident dementia at the first biennial who had missing data from baseline. Five imputations were conducted, and, on the basis of these, 5, 7, 7, 3, and 5 of the 18 subjects were imputed to have had dementia at baseline. We used the first imputation in our incidence analyses to take these cases into account.
Age-specific and sex-specific incidence density rates and 95% CIs are shown in Table 3 for all dementias, AD, VaD, and other dementias. AD was the most common form of incident dementia in this population. The overall incidence rate for all dementias was 14.4/1000 (95% CI, 12.3-16.4); for AD, 11.3 (95% CI, 9.4-13.2); and for VaD, 4.4 (95% CI, 3.2-5.6). For women, the rates were 15.9 (95% CI, 13.0-18.8), 13.2 (95% CI, 10.5-15.9), and 5.3 (95% CI, 3.6-7.0) for all dementias, AD, and VaD; for men, the corresponding rates were 12.5 (95% CI, 9.5-15.5), 8.8 (95% CI, 6.3-11.3), and 3.3 (95% CI, 1.8-4.9), respectively.
The incidence rates for all dementia and AD increased with age in both sexes, approximately doubling every 5 years. A less consistent age trend was evident for VaD. Women had higher incidence rates than men for all dementia and AD in most age groups. Women aged 80 to 89 had higher rates of VaD compared with men. Rates for "other dementias" were based on very small sample sizes. When Cox models were constructed, neither sex nor education was associated with any of the outcomes, although there was a trend for education to be inversely associated with dementia and AD (all dementia: HR = 0.94; 95% CI, 0.87-1.02; AD: HR = 0.92; 95% CI, 0.84-1.01; VaD: HR = 1.07; 95% CI, 0.92-1.25). The presence of 1 or 2 APOE-E4 alleles was the sole statistically significant predictor of all dementias (HR = 2.89; 95% CI, 1.88-4.46), AD (HR = 3.27; 95% CI, 2.03-5.28), and VaD (HR = 3.33; 95% CI, 1. 34-8.27) , adjusting for sex and years of education.
DISCUSSION
In this population-based study of Japanese Americans living in King County, WA, the overall incidence rate for all dementias was 14.4/1000 (95% CI, 12.3-16.5) in 11,638 person-years, with women having an incidence rate of 15.9/ 1000 (95% CI, 13.0-18.8) and men 12.5/1000 (95% CI, 9.5-15.5). The overall incidence rate for AD was 11.3/1000 (13.2/1000 for women and 8.8/1000 for men) and for VaD was 4.4/1000 (5.3/1000 for women and 3.3/1000 for men). This is the first time that rates for Japanese Americans can be compared by sex within 1 population, the only other study of Japanese Americans being the Honolulu-Asia Aging Study, which was conducted among only men.
Comparison With Other Large Population-based Studies
Age-specific and sex-specific incidence rates for dementia in the Kame Project were generally close to those found in other studies. The rates in the oldest participants (85 +) in our study were higher than those in the Rotterdam Study, 18 but the small number of cases in this age stratum may obscure true differences. Women aged 85 + in Kame had higher rates than those from the Framingham Study, 19 but among older men, rates were similar. Incidence rates from France (PAQUID) 20 were similar to those in Kame for all dementias and AD, except at ages 70 to 74 and 80 to 84, where PAQUID's rates were somewhat higher. Differences in cognitive screening tests, sampling procedures, case definitions, and other methodologic applications may hamper the comparison of rates between studies. Our rates were consistent with a meta-analysis of 23 studies. 21 An unexpected finding in our study was the apparent higher rate of VaD seen in women: 5.3 (95% CI, 3.6-7.0), compared with men: 3.3 (95% CI, 1.8-4.9). In Hiroshima, 22 comparable rates averaged out to be about half that seen in Kame women.
We could not conduct a meta-analysis comparing incidence rates from Kame with those from Hiroshima, 22 Honolulu, 3 and ACT 23 in Seattle, WA because of minor differences in methodologic applications at the 4 sites, such as using different CASI cutoff points and use of different clinical criteria in the published incidence papers. Descriptively, age-specific rates for AD were similar in the Kame Project and Hiroshima 22 and in whites studied in ACT. 23 For men, HAAS reported lower rates for AD than did the other studies. 3 
Incidence Rates and Sex
Whether women are at higher age-specific risk of dementia/AD than men is still not resolved. In this study, no differences were found. One meta-analysis 24 found that women are about 50% more likely to develop AD, but no difference by sex was found when the outcome was overall incidence of dementia. Jorm and Jolley 21 reported that, although the difference in risk by sex is small, women aged 85 + tend to have higher incidence rates than men. In a study focusing on people aged 90 + , 25 there were no differences by sex. The AHS 22 and ACT 23 also found no differences by sex.
Incidence Rates and Education
Education has been shown in many studies to be associated with incident dementia and AD 26 but about half show no association, and in Kame, education was not statistically significant in the fully adjusted models. However, in models not adjusted for APOE-E4, education was inversely associated with the risk of dementia and AD but not VaD. The fact that education lost statistical significance when APOE-E4 was added to the model may be related to lower statistical power due to reduced sample size (not all participants donated blood). Consistent with this view, the point estimate did not change for AD and increased only slightly for all dementias. Education should be considered in the context of other early-life exposures, 27 such as perinatal conditions, early-life brain development and body growth. Socioeconomic conditions, environmental enrichment, and neural reserve are among the many variables that may preserve brain function across the life span. Sharp and Gatz 26 extended this model to variables that occur during adulthood such as healthy lifestyle and cognitive stimulation and their associations with reduced risk for dementia in late-life. In addition, several studies that consider both intelligence (IQ) and education simultaneously show that including IQ in the predictive model nullifies the significant association with education. 27, 28 In representative autopsy studies, risk factors for disease expression such as education and head circumference are not related to neuropathology. 29, 30 In different populations, variables related to achieved education in childhood and/or adulthood may be surrogates for years of formal education. In the Kame Project, for example, verbal IQ from the National Adult Reading Test-Revised was correlated with education 0.42 (P = 0.0001). 31 The direct measurement of years of education may have different meanings in different cultures and cohorts. 26 
Incidence Rates and APOE
The frequency of APOE-E4 in Kame is similar to that of other Japanese populations. 32 Table 4 displays the genotypes and isoform frequencies for APOE in Kame. Kame genotypes were just within the Hardy-Weinberg equilibrium (P = 0.053).
The presence of 1 or more E4 alleles strongly predicted VaD and AD, and with similar magnitude (HR = 3.33; 95% CI, 1.34-8.27 for VaD; and HR = 3.27; 95% CI, 2.03-5.28 for AD). Studies of the association between APOE-E4 and VaD are equivocal. A meta-analysis of Chinese Han showed a pooled odds ratio of 2.07 (95% CI, 1.69-2.53) for VaD. 33 However, another study of an older Japanese population conducted in Hisayama, Japan found no association between E4 and VaD (risk ratio = 1.08; P = 0.86). 34 In HAAS, no association was found between APOE-E4 and incident VaD (relative risk 1.27; 95% CI, 0.33-4.83). 3 Among white populations, the Canadian Study of Health and Aging found an association between E4 and incident VaD (odds ratio = 3.13; 95% CI, 1.76-5.55), 35 and the Cache County study 36 also reported a significant HR for 2 alleles (HR = 4.4; 95% CI, 1.6-12.5), with the HR for 1 allele approaching significance (P = 0.08). In the Rotterdam Study, 37 there was also a strong tendency for E4 to be associated with clinically diagnosed VaD [E2E4: HR = 3.2 (95% CI, 1.0-10.8); E3E4: HR = 1.8 (95% CI, 0.9-3.4); and E4E4: HR = 8.6 (95% CI, 2.9-25.2)]. We speculate that as the clinical diagnosis of VaD in our study included possible and probable VaD, VaD patients could have comorbid AD, strengthening the association with APOE-E4.
Strengths and Limitations
The Kame Project is representative of the Japanese American population of King County aged 65 and over and is the first population-based study of dementia to include Japanese American women. Our study had a high cutoff point on the CASI for screening for incident dementia (<87/100), so it is likely that most of the incident cases that occurred during the follow-up period were captured. We asked the cohort for blood during the first incidence wave, and 39.5% refused. Participants in the study who refused blood donation and were thus missing APOE genotypes (n = 725) were older (mean = 72.9 y) (P < 0.001), more likely to be women (P < 0.001), and somewhat less educated (mean = 12.3 y) (P < 0.001) than those who agreed. Therefore, those with complete APOE data in our study may have fewer risk factors for dementia, and analyses using APOE may be biased toward the null. A limitation is that we have no autopsy results and the associations with risk factors depend on the accuracy of the clinical diagnosis of dementia subtypes. The likelihood of misclassification is minimized by following strict, clinical diagnostic criteria that are routinely used in large epidemiologic studies and adjudicating all cases by a consensus committee and monitoring dementia cases annually for disease progression. Further analyses will delineate Asian versus Western dietary and cultural patterns that may be associated differentially with incident dementia in this cohort; we have previously published, among others, associations examining acculturation and early-life exposures, [38] [39] [40] [41] estrogen and dietary soy isoflavones, 42 alcohol consumption, 43 and consumption of fruit and vegetable juices. 44 
